To test the ability of cells with modified gene expression levels to form tumor spheres, we generated tumor spheres as previously described [18 (link)]. In detail, the adherent growing cell lines were dissociated into single cells using trypsin/EDTA and 2000 single cells per well seeded in ultra-low attachment 6-well plates (Corning, NY, USA) using serum-free MEBM (Lonza, Basel, Switzerland) medium (SFM) supplemented with 1xB27 supplement (Gibco), 20 ng/ml human epidermal growth factor EGF (Peprotech, Hamburg, Germany), 10 ng/ml human basic fibroblast growth factor FGF (Peprotech), 20 IU/ml heparin (Baxter, Vienna, Austria), and 1% antibiotic/antimycotic solution (Thermo Fisher Scientific, containing 10,000 units/mL of penicillin; 10,000 μg/mL of streptomycin; and 25 μg/mL of Gibco Amphotericin B). After 14 days, the number of spheres was counted using a bright-field microscope in three independent replicates.
Free full text: Click here